 | |
| Clinical data | |
|---|---|
| Other names | Cypionyl megestrol acetate; Megestrol acetate 3β-cypionate; Megestrol acetate 3β-cyclopentylpropionate; Progestin No. 1; Progestin I; Progestagen I; 17α-Acetoxy-6-dehydro-6-methylprogesterone 3β-cypionate; 17α-Acetoxy-6-methylpregna-4,6-diene-3,20-dione 3β-cypionate |
| Routes of administration | By mouth[1][2] |
| Drug class | Progestin;Progestogen;Progestogen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C32H46O5 |
| Molar mass | 510.715 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Cymegesolate (developmental code nameProgestin No. 1), also known ascypionyl megestrol acetate or asmegestrol acetate 3β-cypionate, is aprogestin medication which was never marketed.[1][2][3][4][5][6] It was developed inChina in the late 1970s and early to mid 1980s for use as ahormonal contraceptive.[1][2][3][4][5][6] The medication was formulated at a dose of 50–100 mg in combination with a "trace" dose of 0.25–0.5 mgquinestrol as a long-lasting, once-a-monthcombined oral contraceptive pill.[1][2] This combination has been studied in 1,213 women across a total of 9,651 menstrual cycles, with contraceptive effectiveness of over 99.13% and "very fewside effects."[1] At the high dose (100 mg / 0.5 mg), it showed ananovulation rate of only about 60%, and instead mediated its contraceptive effects via a markedanti-implantation effect.[2]
Cymegesolate, also known as megestrol acetate 3β-cypionate, as well as 17α-acetoxy-6-dehydro-6-methylprogesterone 3β-cyclopentylpropionate or 17α-acetoxy-6-methylpregna-4,6-diene-3,20-dione 3β-cyclopentylpropionate, is asyntheticpregnanesteroid and aderivative ofprogesterone and17α-hydroxyprogesterone.[1][2] It is the C3βcypionate (cyclopentylpropionate)ester ofmegestrol acetate.[1][2] A closely related medication isacetomepregenol (mepregenol diacetate; also known as megestrol 3β,17α-diacetate), which, in contrast, has been marketed.[7][8][9][10]
Note that 3,17-diacetoxy-6-methylpregna-4,6-dien-20-one (1b), a structural analog of compound 1a, is certified in Russia under the trade name acetomepregnol and recommended for therapeutic purposes in gynecological practice and as a contraceptive preparation in combination with estrogens [4].
Gestagens are widely used in medicine as drugs for the treatment of breast and uterine tumors, endometriosis, uterine bleeding, and premenstrual syndrome, as a means of hormonal therapy and maintenance of pregnancy, and as contraceptives [1, 2]. In clinics, drugs of this group are represented by acetomepregenol (AMP), medroxyprogesterone acetate (MPA), levonorgestrel, progesterone, didrogesterone, etc. [1].
